Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bolt-on deals
Biotech
After 11-month romance, GSK buys oligonucleotide partner Elsie
After taking 11 months to get to know Elsie and its oligonucleotide platform, the Big Pharma has bought the West Coast biotech for up to $50 million.
Nick Paul Taylor
Jun 6, 2024 9:41am
BMS more likely to bet on bolt-ons after recent buying spree
Feb 2, 2024 10:59am
Novartis knows what's ahead as peers enter radiopharmaceuticals
Oct 24, 2023 7:00am
Biopharma won’t stop betting big on M&A earnouts as payouts slow
Oct 17, 2023 6:00am
M&A values halve, volumes plunge. Will we ever see deals again?
Dec 8, 2022 8:25am
Galapagos takes M&A plunge, spending $251M for CAR-T push
Jun 22, 2022 4:36am
